EULAR 大血管炎影像学建议对巨细胞动脉炎诊断的影响:ARTESER 登记研究结果
ARTESER 为西班牙风湿病学会支持的多中心观察性回顾研究,纳入 26 家医院 2013 年 6 月 1 日至 2019 年 3 月 29 日诊断的 1675 例巨细胞动脉炎患者。结果显示活检阳性 776 例(46.3%)、超声阳性 503 例(30.0%)、PET 阳性 245 例(14.6%)、MRI/CT 血管造影阳性 64 例(3.8%)。2013 至 2019 年超声使用从 25.8% 升至 52.9%、PET 从 12.3% 升至 19.6%,而颞动脉活检从 50.3% 降至 33.3%;2018 年 EULAR 建议发布后,超声取代活检成为一线诊断检查。
要点
- 活检仍是确认巨细胞动脉炎最广泛使用的诊断检查,但影像学作为诊断工具近年使用增长。
- 2013 至 2019 年超声使用从 25.8% 升至 52.9%,PET 从 12.3% 升至 19.6%,颞动脉活检从 50.3% 降至 33.3%。
- 2018 年 EULAR 建议发布后,超声取代活检成为一线诊断检查,活检在三分之一、PET 在五分之一的病例中施行。
核心结论
- 活检是确认巨细胞动脉炎最广泛使用的诊断检查,但影像学作为诊断工具近年使用增长;2018 年 EULAR 建议发布后,超声取代活检成为一线诊断检查。
研究设计与样本
- 多中心观察性回顾研究,由西班牙风湿病学会支持,纳入 26 家医院 2013 年 6 月 1 日至 2019 年 3 月 29 日诊断的 1675 例巨细胞动脉炎患者;金标准为主治医师根据临床标准并参考实验室检查、影像学检查(超声、PET 及 MRI/CT 血管造影)和可获得的颞动脉活检作出的判断。
诊断标准与关键数值
- 活检阳性 776 例(46.3%)。
- 超声阳性 503 例(30.0%)。
- PET 阳性 245 例(14.6%)。
- MRI/CT 血管造影阳性 64 例(3.8%)。
临床应用与阅片要点
- 2013 至 2019 年诊断中超声使用从 25.8% 升至 52.9%,PET 从 12.3% 升至 19.6%,颞动脉活检从 50.3% 降至 33.3%。
- 2018 年 EULAR 建议发布后,超声取代活检成为一线诊断检查。
- 活检在三分之一、PET 在五分之一的病例中施行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The main study objective was to determine how giant cell arteritis (GCA) is diagnosed in our clinical practice and whether the EULAR recommendations have influenced the diagnostic procedures used.
METHODS: ARTEritis of the Rheumatology Spanish Society -Sociedad Española de Reumatología (ARTESER) is a multicentre observational retrospective study conducted in 26 hospitals with support from the Spanish Society of Rheumatology. All patients diagnosed with GCA between 1 June 2013 and 29 March 2019 were included. The gold standard for the diagnosis of GCA was the judgement of the physician in charge, according to clinical criteria, supported by data available from laboratory tests, imaging studies (ultrasound, positron emission tomography (PET) and MRI/CT angiography) and temporal artery biopsy (TAB) when available.
RESULTS: We included 1675 patients with GCA (mean age±SD (76.9±8.1) years, 1178 women (70.3%)). Of these, 776 patients had a positive TAB (46.3%), 503 (30.0%) positive ultrasound, 245 positive PET (14.6%) and 64 positive MRI/CT angiography (3.8%). These percentages changed substantially over the study. From 2013 to 2019, the use of ultrasound in diagnosis grew from 25.8% to 52.9% and PET from 12.3% to 19.6%, while use of TAB decreased from 50.3% to 33.3%.
CONCLUSIONS: Biopsy was the most widely used diagnostic test for confirming GCA, but use of imaging as a diagnostic tool has grown in recent years. Following publication of the 2018 EULAR recommendations, ultrasound has displaced biopsy as the first-line diagnostic test; TAB was performed in a third and PET in a fifth of cases.
引用
- De Miguel E, Sanchez-Costa JT, Estrada P, et al. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register. RMD Open. 2022. PMID: 36597988. doi:10.1136/rmdopen-2022-002507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。